278
Metagenomi Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
258
FY25:
166
(positive)
Change from FY23 to FY25
millions USD
FY23:
86.6
FY24:
66.6
FY25:
55.6
Total assets
Change from FY23 to FY25
millions USD
FY23:
365
FY24:
325
FY25:
221
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
68.9
FY24:
37.3
FY25:
22.9
(negative)
Change from FY23 to FY25
millions USD
FY23:
80.8
FY24:
52.4
FY25:
39.6
(positive)
Change from FY23 to FY25
millions USD
FY23:
−136
FY24:
235
FY25:
159
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
325
FY25:
221
All amounts in millions USD